Mary Hames is a seasoned Medical Affairs executive with a proven track record of leading high-performing teams and delivering strategic impact across rare disease, diagnostics, and oncology. With a foundation in biochemical genetics and over a decade of industry experience, she has played pivotal roles in clinical operations, launch preparedness, and cross-functional leadership. Known for her ability to navigate complex medical landscapes, Mary has successfully built and led medical teams, advanced companion diagnostics, and driven field strategy across multiple therapeutic areas. Her leadership is marked by scientific rigor, operational excellence, and a deep commitment to improving outcomes for patients with rare and life-threatening conditions.

I’m excited to share my professional journey and the expertise I’ve developed over 41 years in clinical research and drug development. As the President and Founder of New England Clinical Consulting (NECC), I’ve had the privilege of leading clinical operations across the biotech and pharma sectors, working on therapeutic areas ranging from oncology to infectious diseases. Throughout my career, I’ve tackled complex challenges, built high-performing teams, and delivered successful clinical trials from early-phase development to global Phase 3 studies. I’m passionate about advancing clinical research, overseeing CROs, and developing innovative drug development strategies. If you’re interested in clinical operations or collaborating on new projects, I’d love to connect and explore how we can work together to drive impactful results.